Global Postoperative Market Feeding-off Growing Healthcare Industry

Published By : 27 Oct 2016 | Published By : QYRESEARCH

The postoperative pain market relates to easing out the adverse outcomes of any operative process, such as pain, vomiting, nausea, bleeding or sedation. Postoperative pain management programs not only reduce the pain intensity in the patients but also quicken-up the postoperative results and increasing patient comfort. According to National Center for Health Statistics, approximately 100 million surgeries are carried out in the U.S. each year. It’s been perceived that at least 50% of those procedures require postoperative pain medication. Here are some of the primary factors that driving the global market for postoperative pain.

  • Flourishing healthcare industry: Along with the growing market for medical devices and advancements in the field biotechnology, pharmaceutical market is witnessing new peaks in growth rate and this as a result is encouraging innovations in postoperative pain market too.
  • Rising geriatric population: According to Wikipedia, the number of people aged 60 years and over has tripled since 1950, reaching 600 million in 2000 and is projected to reach 2.1 billion market by 2050. This population is predominantly in Asia Pacific which is largely an untapped region in the market for postoperative pain.
  • Growing prevalence of lifestyle and senile diseases: Increased cases of dementias and Alzheimer’s is a result of restless lifestyle which causes reduced diet and lack of nutrition in-take, especially among the urban population. These disorders gradually develop into diseases which require operations and hence fuel the market for postoperative pain.
  • Growing awareness among the end-users: Increasing literacy rate, particularly in Asia Pacific countries such as India and China, and growing popularity of social media is spreading the benefits of postoperative pain drugs and management programs. 

However, a point of concern with postoperative pain drugs such as opioids is that patients tends to get habituated to it. If not monitored by physician and dose is decreased over the course of the treatment, these may also result in death due to drug overdose.

Back To Top